Related Experiment Video

Updated: Jul 25, 2026

Subcutaneous Administration of Muscarinic Antagonists and Triple-Immunostaining of the Levator Auris Longus Muscle in Mice
07:09

Subcutaneous Administration of Muscarinic Antagonists and Triple-Immunostaining of the Levator Auris Longus Muscle in Mice

Published on: September 8, 2011

Pharmacological characterization of muscarinic cholinergic receptors in cat pons and cortex. Preliminary study

H A Baghdoyan1, B X Carlson, M T Roth

  • 1Department of Anesthesia, Pennsylvania State University, College of Medicine, Hershey 17033.

Pharmacology
|February 1, 1994
PubMed

Insights

This study investigated muscarinic acetylcholine receptors (mAChRs) in feline pons, finding evidence for multiple subtypes involved in REM sleep generation. M2 antagonists showed higher binding potency, suggesting their critical role.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Sleep Research

Background:

  • Muscarinic acetylcholine receptors (mAChRs) are crucial for REM sleep generation in the pontine reticular formation.
  • Previous studies suggest the M2 subtype plays a significant role in REM sleep generation within the pons.

Purpose of the Study:

  • To test the hypothesis that M2 antagonists exhibit greater binding potency in the feline pons compared to M1 or M3 antagonists.
  • To investigate the distribution and interaction of different mAChR subtypes in the feline pons.

Main Methods:

  • Competition binding assays were employed using tritiated quinuclidinyl benzilate.
  • Radioligand binding experiments were conducted to assess antagonist potency.
  • Linear regression analyses were used to analyze binding data and identify interactions with multiple sites.

Main Results:

  • The M2-selective antagonist 4-DAMP demonstrated higher potency in displacing radioligand binding than pirenzepine (M1/M2/M4 selective) or AF-DX 116 (M2/M4 selective).
  • Analysis indicated that both 4-DAMP and pirenzepine interacted with more than one mAChR binding site in the feline pons.
  • These findings reveal a heterogeneous population of mAChR subtypes in the feline pons.

Conclusions:

  • The feline pons contains a mixture of muscarinic acetylcholine receptor subtypes.
  • The results support the involvement of multiple mAChR subtypes in the mediation of REM sleep.
  • Further research is warranted to elucidate the specific roles of each subtype in REM sleep regulation.

More Related Videos

Bladder Smooth Muscle Strip Contractility as a Method to Evaluate Lower Urinary Tract Pharmacology10:26

Bladder Smooth Muscle Strip Contractility as a Method to Evaluate Lower Urinary Tract Pharmacology

Published on: August 18, 2014

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development07:02

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development

Published on: February 11, 2019

Related Concept Videos

Cholinergic Receptors: Muscarinic01:25

Cholinergic Receptors: Muscarinic

The pharmacological actions of acetylcholine are elicited via its binding to two families of cholinergic receptors or cholinoceptors, namely, muscarinic and nicotinic receptors. Muscarinic receptors are G protein-coupled receptors and have five subtypes, M1–M5. All mAChR subtypes are activated by acetylcholine and blocked by the antagonist, atropine. 
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+. Activation...
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:22

Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
Direct-Acting Cholinergic Agonists: Pharmacokinetics01:31

Direct-Acting Cholinergic Agonists: Pharmacokinetics

Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
Direct-Acting Cholinergic Agonists: Pharmacological Actions00:59

Direct-Acting Cholinergic Agonists: Pharmacological Actions

Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship01:29

Cholinergic Antagonists: Chemistry and Structure-Activity Relationship

Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic antagonists are called...
Cholinergic Antagonists: Pharmacological Actions01:28

Cholinergic Antagonists: Pharmacological Actions

Antimuscarinic drugs block muscarinic receptors in multiple systems, including the gut, eye, smooth muscles, respiratory tract, cardiovascular, and central nervous systems. They produce similar effects with varying selectivity depending on the specific agent and tissue. Here are the key pharmacological actions of antimuscarinics:
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...